Category : Search result: pharmaceutical pricing


Instacart Halts AI Price Experiments After Criticism

Instacart has terminated its AI-driven dynamic pricing tests following user criticism. The grocery delivery service faced scrutiny for algorithm-based price fluctuations. Learn what this means for Canadian shoppers.

Fox Host Debunks Trump's 600% Drug Price Cut Claim

A Fox News anchor delivered a brutal math lesson on air, highlighting the impossibility of Trump's claim about slashing prescription drug prices by 600%. See the reality vs. perception clash unfold.

Health Canada Approves Drug for Rare Disease

Health Canada has granted approval for a new pharmaceutical treatment targeting a rare disease, offering hope for patients. Learn about the regulatory decision and its impact.

Pfizer 2026 profit forecast below expectations

Pfizer projects 2026 profits below Wall Street estimates due to a steep drop in COVID product sales and loss of exclusivity for key drugs. Get the full business analysis.

China's Biopharma Surge Challenges Global Drug Leaders

China's biopharma industry is accelerating, fueled by record investment and streamlined supply chains. With faster development times and massive deals like AstraZeneca's $5.2B pact, the global drug innovation race is heating up. Discover the shift from ou

Eli Lilly cuts price of obesity drug Zepbound

Pharmaceutical giant Eli Lilly has reduced the price of its obesity medication Zepbound to improve patient access. The move comes amid growing demand for GLP-1 drugs in Canada and globally.

NB EUB cancels carbon cost adjuster removal

New Brunswick Energy and Utilities Board reverses decision to remove carbon cost adjustor. Learn how this affects energy prices and provincial climate policy.

Smith: Industrial Carbon Tax Must Be Affordable

Alberta Premier Danielle Smith states the timeline for the $130/tonne industrial carbon tax must align with what industry can afford, following a new energy deal with Ottawa.

Grey Bruce drug disposal nets meds for hockey tickets

Grey Bruce residents exchanged unused pharmaceuticals for Barrie Colts hockey tickets in a successful medication safety initiative. Learn how this program helps combat opioid misuse and environmental contamination.

Dipharma's Novel Method Detects Nitrosamine Risks

Dipharma publishes a peer-reviewed study unveiling a novel method to detect and characterize nitrosamine impurities in Active Pharmaceutical Ingredients, enhancing drug safety and regulatory compliance.

Novo Nordisk Alzheimer's Drug Trials Fail

Danish pharmaceutical giant Novo Nordisk faces major setback as Alzheimer's drug trials fail. Learn how this impacts the weight-loss leader's expansion plans.

Eli Lilly Reaches $1 Trillion Valuation Milestone

Eli Lilly becomes the first pharmaceutical company to achieve a US$1 trillion market valuation, driven by unprecedented demand for its weight-loss treatments. Discover how this milestone reshapes the industry.

Denmark compensates for Novo Nordisk vision loss

Danish authorities provide compensation to patients experiencing vision loss linked to Novo Nordisk medications. Learn about the pharmaceutical safety developments affecting Canadian consumers.

J&J buys Halda Therapeutics for $3.05 billion

Johnson & Johnson expands its oncology portfolio with $3.05 billion acquisition of Halda Therapeutics, strengthening its cancer treatment pipeline. Learn about this major healthcare investment.

Barbados Launches US$200M Life Sciences Hub

Barbados partners with EarlyHealth Group to build a US$200 million life sciences hub, positioning the island as the Caribbean's premier pharmaceutical and research centre.

Page 1 of 2